LEXURE for Post-Stroke Aphasia

ConditionAphasia

Trial statusRecruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexAll

Age19+

SponsorNunaps Inc

About this trial

This study evaluates the efficacy of digital language rehabilitation using LEXURE for the treatment of post-stroke aphasia. Half of participants will receive structured language training using the LEXURE application, while the other half will receive workbook-based language training as an active comparator.

Eligibility criteria

Qualifiers

Diagnosed with hemorrhagic or ischemic stroke

At least 3 months have elapsed since stroke onset

History of aphasia resulting from stroke

Aphasia Quotient (AQ) score between 26 and 90 (inclusive) on the Korean version of the Western Aphasia Battery (K-WAB) or the Paradise Korean version of the Western Aphasia Battery-Revised (PK-WAB-R)

Disqualifiers

Diagnosed with language impairment due to causes other than stroke (e.g., traumatic brain injury, brain tumor, or neurodegenerative disease)

History of language impairment due to developmental disorders

Currently receiving speech-language therapy or participating in another clinical trial related to language function

Currently receiving medication for severe psychiatric disorders (e.g., bipolar disorder, major depressive disorder, schizophrenia, alcohol dependence, or substance abuse)

Trial design

Treatments tested in this trial

LEXURE
Workbook

Treatment groups

116 Participants

are divided into 2 treatment groups

Locations12

Select a site below to view it on the map.

Sponsors and collaborators

Nunaps Inc

Lead sponsor

Source ClinicalTrials.gov